XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-In-Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total Common Equity
Noncontrolling Interests in Subsidiaries
Balance at Oct. 31, 2022 $ 24,739,000 $ 73,000 $ 30,635,000 $ (6,208,000) $ 1,409,000 $ 25,909,000 $ (1,170,000)
Balance (in Shares) at Oct. 31, 2022   7,321          
Stock based compensation expense 5,000   5,000     5,000  
Vested share units granted to Directors 26,000   26,000     26,000  
Vested share units granted to Directors (in Shares)   2          
Stock options exercised 1,226,000 $ 1,000 1,225,000     1,226,000  
Stock options exercised (in Shares)   113          
Distributions to noncontrolling interests in subsidiaries (1,850,000)         (1,850,000)
Net income (loss) 46,000     419,000   419,000 (373,000)
Dividends declared (541,000)     (541,000)   (541,000)  
Net unrealized (gain) loss on interest rate swap contracts (450,000)       (450,000) (450,000)
Balance at Jan. 31, 2023 23,201,000 $ 74,000 31,891,000 (6,330,000) 959,000 26,594,000 (3,393,000)
Balance (in Shares) at Jan. 31, 2023   7,436          
Balance at Oct. 31, 2022 24,739,000 $ 73,000 30,635,000 (6,208,000) 1,409,000 25,909,000 (1,170,000)
Balance (in Shares) at Oct. 31, 2022   7,321          
Net income (loss) (240,000)            
Net unrealized (gain) loss on interest rate swap contracts (557,000)            
Balance at Apr. 30, 2023 22,384,000 $ 74,000 32,043,000 (6,605,000) 852,000 26,364,000 (3,980,000)
Balance (in Shares) at Apr. 30, 2023   7,446          
Balance at Jan. 31, 2023 23,201,000 $ 74,000 31,891,000 (6,330,000) 959,000 26,594,000 (3,393,000)
Balance (in Shares) at Jan. 31, 2023   7,436          
Stock awards granted to directors 140,000   140,000     140,000  
Stock awards granted to directors (in Shares)   9          
Stock based compensation expense 5,000   5,000     5,000  
Stock options exercised 7,000   7,000     7,000  
Stock options exercised (in Shares)   1          
Distributions to noncontrolling interests in subsidiaries (204,000)         (204,000)
Net income (loss) (286,000)     97,000   97,000 (383,000)
Dividends declared (372,000)     (372,000)   (372,000)  
Net unrealized (gain) loss on interest rate swap contracts (107,000)       (107,000) (107,000)
Balance at Apr. 30, 2023 22,384,000 $ 74,000 32,043,000 (6,605,000) 852,000 26,364,000 (3,980,000)
Balance (in Shares) at Apr. 30, 2023   7,446          
Balance at Oct. 31, 2023 18,476,000 $ 74,000 32,074,000 (8,968,000) 1,336,000 24,516,000 (6,040,000)
Balance (in Shares) at Oct. 31, 2023   7,450          
Stock based compensation expense 1,000   1,000     1,000  
Distributions to noncontrolling interests in subsidiaries (180,000)         (180,000)
Net income (loss) (666,000)     (512,000)   (512,000) (154,000)
Dividends declared (372,000)     (372,000)   (372,000)  
Net unrealized (gain) loss on interest rate swap contracts (530,000)       (530,000) (530,000)
Net unrealized loss on investment in U.S. Treasury securities available-for-sale (7,000)       (7,000) (7,000)
Balance at Jan. 31, 2024 16,722,000 $ 74,000 32,075,000 (9,852,000) 799,000 23,096,000 (6,374,000)
Balance (in Shares) at Jan. 31, 2024   7,450          
Balance at Oct. 31, 2023 18,476,000 $ 74,000 32,074,000 (8,968,000) 1,336,000 24,516,000 (6,040,000)
Balance (in Shares) at Oct. 31, 2023   7,450          
Net income (loss) (267,000)            
Net unrealized (gain) loss on interest rate swap contracts (273,000)            
Balance at Apr. 30, 2024 16,533,000 $ 75,000 32,215,000 (9,692,000) 1,043,000 23,641,000 (7,108,000)
Balance (in Shares) at Apr. 30, 2024   7,458          
Balance at Jan. 31, 2024 16,722,000 $ 74,000 32,075,000 (9,852,000) 799,000 23,096,000 (6,374,000)
Balance (in Shares) at Jan. 31, 2024   7,450          
Stock awards granted to directors 141,000 $ 1,000 140,000     141,000  
Stock awards granted to directors (in Shares)   8          
Distributions to noncontrolling interests in subsidiaries (600,000)         (600,000)
Net income (loss) 399,000     533,000   533,000 (134,000)
Dividends declared (373,000)     (373,000)   (373,000)  
Net unrealized (gain) loss on interest rate swap contracts 257,000       257,000 257,000
Net unrealized loss on investment in U.S. Treasury securities available-for-sale (13,000)       (13,000) (13,000)
Balance at Apr. 30, 2024 $ 16,533,000 $ 75,000 $ 32,215,000 $ (9,692,000) $ 1,043,000 $ 23,641,000 $ (7,108,000)
Balance (in Shares) at Apr. 30, 2024   7,458